Micell Forms Alliance for the Development of Drug-Eluting Stents, Balloons

 

January 13, 2009

January 13, 2009 - Micell Technologies, a development-stage biomedical device company dedicated to developing innovative interventional cardiology systems, has obtained the rights to Maxcor's CE-marked Genius MAGIC Cobalt Chromium Coronary Stent System for the purpose of developing and marketing drug-eluting stents (DES) based on Micell's prop coating technology.

The companies also entered into an agreement to develop drug-eluting balloon (DEB) products for cardiovascular applications.

Micell has developed a drug-polymer formulation that is said to precisely and consistently control drug elution and the duration of polymer exposure. The coating has the potential to deliver a precise therapeutic solution for coronary artery disease without the long-term safety concerns of currently available DES. The in-licensing of the Genius MAGIC Cobalt Chromium Coronary Stent System provides what the company believes is the optimal bare-metal stent product for the further development of the company's drug-polymer coating. The company believes that DEB will advance the treatment of many clinical conditions while minimizing risks or side-effects of these treatments.

For more information: www.micell.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.